A New Therapeutic Era for Sickle Cell Disease
A New Therapeutic Era for Sickle Cell Disease https://pediatricsnationwide.org/wp-content/uploads/2026/09/Gold-Circles-1024x320.jpg 1024 320 Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gif
Transformative therapies, coupled with novel approaches to supportive care, provide increasing hope for a normal life. For more than 100 years, progress in sickle cell disease (SCD) treatment has been slow. Its mainstay treatment, hydroxyurea, approved about 30 years ago, is a repurposed cancer drug. Its first curative therapy, allogeneic hematopoietic stem cell transplant (HSCT),…